Chicago
Eight source-checked providers are available now while outreach, corrections and measurement are validated.
Explore Chicago care →Expansion standard · Updated August 13, 2026
Chicago is the only live pilot. Dallas–Fort Worth, Atlanta and Seattle are the first research cohort—not live directories. A city earns a public launch only when its provider evidence, correction workflow and owner value meet the standard below.
Coverage
Population and growth help choose where to investigate. They do not prove that enough suitable providers, owner demand or editorial capacity exists to launch.
Eight source-checked providers are available now while outreach, corrections and measurement are validated.
Explore Chicago care →A large, fast-growing metro that will test whether service areas can be represented accurately across a broad suburban footprint.
A high-growth metro that offers a useful operating contrast with Dallas–Fort Worth.
A sizable, growing market for testing whether providers value richer profile and monitoring tools without paid ranking.
Scale-cohort watchlist: Houston, Washington, D.C., Phoenix, Miami–Fort Lauderdale, New York City and Los Angeles. Order can change when provider supply, search demand, partnership access and review cost are measured.
Public launch gate
Research pages stay out of search. The public directory appears only after these measurable requirements pass.
At least 20 source-checked providers across four care categories, with every specialty claim tied to a provider-controlled source.
Sources reviewed within 30 days of launch; at least 80% of specialty fields supported by public evidence.
At least five profiles confirmed by the provider and a working path for free corrections, claims and removal requests.
A named reviewer, review register, stale-data rules and one completed source recheck before expansion continues.
Search and community evidence for the special-needs wedge, plus a path to measure useful matcher completions and provider visits without sending pet details to analytics.
Agentic AI with a human release gate
The workflow uses AI for bounded, reviewable tasks and keeps publication authority with a person.
Agents locate provider-controlled pages and assemble a research queue. Search snippets, reviews and model output are not accepted as capability evidence.
Agents propose species, needs, settings and service-area fields with the exact source URL and an evidence summary.
A separate pass flags missing dates, conflicting pages, ambiguous claims and unsupported credentials. Low confidence means no publication.
A named editor opens the source, confirms the close paraphrase and accepts or rejects every public field.
Automated checks can flag broken or changed sources. They never silently rewrite a listing or renew its review date.
Machine-readable records expose market, source, review date, limitations and ranking rules so other agents can cite rather than guess.
Monetization and sustainability
Free basic inclusion remains. Paid tools can add richer presentation, update alerts, claim workflows or reporting, but cannot alter Care Match score, evidence labels or correction priority.
A market sponsor or contextual affiliate may appear only in a clearly labeled block outside provider cards, personalized results and due-diligence guidance.
Ads remain off until traffic is useful enough to evaluate. If enabled, use a small number of stable in-page units after complete content sections—never overlays, fake listings or units next to controls.
Each market carries a review-hours budget, freshness target and market-level profit-and-loss view. Expansion pauses when stale records or unresolved corrections exceed the service standard.
The public matcher stays static and local. AI research runs in batches against changed or new sources instead of on every visitor request.
Commercial relationships, AI assistance, methodology changes and material corrections are disclosed where people and downstream agents can see them.
Decision sources
Care providers outside Chicago
Providers can suggest a business and share public evidence now. Research status does not guarantee inclusion or a launch date.